Tumor-derived extracellular vesicles mediate cell-specific uptake and facilitate enhanced doxorubicin delivery in breast cancer

BackgroundChemotherapy suppresses tumor growth and metastasis, but its efficacy is limited by non-specificity, systemic toxicity, poor accumulation and side effects. Extracellular vesicles (EVs) derived from cells have recently been tested for carrying drugs due to their biocompatibility, stability,...

詳細記述

書誌詳細

主要な著者:	Dhananjay B. Alagundagi, Mahima Rachel Thomas, Vinay C. Sangamesh, Vinay Kumar J Rajendra, Vijith V. Shetty, Shama Prasada Kabekkodu, Praveenkumar Shetty, Prakash Patil
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2026-01-01
シリーズ:	Frontiers in Pharmacology
主題:	breast cancer cellular uptake doxorubicin drug delivery extracellular vesicles nanocarriers
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1744895/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!